Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Laurence

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Social Science & Medicine (1982)|February 3, 2024
Comparing disease specific catastrophic cost estimates using longitudinal and cross-sectional designs: The example of tuberculosisTakuya Yamanaka, Mary Christine Castro, Julius Patrick Ferrer, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 8, 2010
Chemoradiotherapy with or without induction chemotherapy for locally advanced pancreatic cancer: a UK multi-institutional experienceR Gillmore, V Laurence, S Raouf, et al.
European Journal of Cancer (Oxford, England : 1990)|September 15, 2012
Cabazitaxel in patients with advanced solid tumours: results of a Phase I and pharmacokinetic studyV Diéras, A Lortholary, V Laurence, et al.
IJTLD Open|July 5, 2024
Health system costs of providing outpatient care for diabetes in people with TB in the PhilippinesT Yamanaka, M C Castro, J P Ferrer, et al.
Plos One|January 25, 2024
Costs incurred by people with co-morbid tuberculosis and diabetes and their households in the PhilippinesTakuya Yamanaka, Mary Christine Castro, Julius Patrick Ferrer, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2014
Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countriesGwenan M Knight, Ulla K Griffiths, Tom Sumner, et al.
Journal of Patient-Reported Outcomes|April 7, 2021
Cultural and linguistic adaptation of the multi-dimensional OXCAP-MH for outcome measurement of mental health among people living with HIV/AIDS in Uganda: the Luganda versionKenneth R Katumba, Yoko V Laurence, Patrick Tenywa, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer. the role of clinical responseJ-Y Pierga, E Mouret, V Laurence, et al.
Cancer|March 27, 2001
Effect of adjuvant chemotherapy on outcome in patients with metastatic breast carcinoma treated with first-line doxorubicin-containing chemotherapyJ Y Pierga, B Asselain, M Jouve, et al.
Breast (Edinburgh, Scotland)|September 30, 2004
Characteristics and outcome of 1755 operable breast cancers in women over 70 years of ageJ-Y Pierga, V Girre, V Laurence, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Social Science & Medicine (1982)|February 3, 2024
Comparing disease specific catastrophic cost estimates using longitudinal and cross-sectional designs: The example of tuberculosisTakuya Yamanaka, Mary Christine Castro, Julius Patrick Ferrer, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 8, 2010
Chemoradiotherapy with or without induction chemotherapy for locally advanced pancreatic cancer: a UK multi-institutional experienceR Gillmore, V Laurence, S Raouf, et al.
European Journal of Cancer (Oxford, England : 1990)|September 15, 2012
Cabazitaxel in patients with advanced solid tumours: results of a Phase I and pharmacokinetic studyV Diéras, A Lortholary, V Laurence, et al.
IJTLD Open|July 5, 2024
Health system costs of providing outpatient care for diabetes in people with TB in the PhilippinesT Yamanaka, M C Castro, J P Ferrer, et al.
Plos One|January 25, 2024
Costs incurred by people with co-morbid tuberculosis and diabetes and their households in the PhilippinesTakuya Yamanaka, Mary Christine Castro, Julius Patrick Ferrer, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2014
Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countriesGwenan M Knight, Ulla K Griffiths, Tom Sumner, et al.
Journal of Patient-Reported Outcomes|April 7, 2021
Cultural and linguistic adaptation of the multi-dimensional OXCAP-MH for outcome measurement of mental health among people living with HIV/AIDS in Uganda: the Luganda versionKenneth R Katumba, Yoko V Laurence, Patrick Tenywa, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer. the role of clinical responseJ-Y Pierga, E Mouret, V Laurence, et al.
Cancer|March 27, 2001
Effect of adjuvant chemotherapy on outcome in patients with metastatic breast carcinoma treated with first-line doxorubicin-containing chemotherapyJ Y Pierga, B Asselain, M Jouve, et al.
Breast (Edinburgh, Scotland)|September 30, 2004
Characteristics and outcome of 1755 operable breast cancers in women over 70 years of ageJ-Y Pierga, V Girre, V Laurence, et al.
Pageof 5